Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $38.2500 (4.08%) ($35.7200 - $38.6000) on Mon. Jul. 2, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.74% (three month average) | RSI | 36 | Latest Price | $38.2500(4.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.6% a day on average for past five trading days. | Weekly Trend | ATRA declines -8.7% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(51%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.87% in a week (0% probabilities). VXX(-15%) VIXM(-14%) TLT(-14%) UUP(-12%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.87% (StdDev 3.74%) | Hourly BBV | 0 () | Intraday Trend | 5.7% | | | |
|
1 - 5 Day Possible Target | $23.16(-39.45%) | Resistance Level | $42.77 | 5 Day Moving Average | $37.55(1.86%) | 10 Day Moving Average | $40.65(-5.9%) | 20 Day Moving Average | $42.77(-10.57%) | To recent high | -25.7% | To recent low | 8.8% | Market Cap | $2.842b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |